Additionally, due to our inclusion criteria, the registry included patients with very heterogeneous backgrounds, ranging from confirmed complement-mediated TMAs to various secondary TMAs not driven by bacterial infection or ADAMTS13 deficiency. Here, ADAMTS13 is linked to bacterial infectious disease.